Skip to content
healthcare.dev

Fondaparinux Sodium

NDC 67457-584, fondaparinux sodium, injection, solution, from Mylan Institutional LLC.

Product NDC
67457-584
Status
Listed
Labeler
Mylan Institutional LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021345
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67457-584 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FONDAPARINUX SODIUM7.5 mg/.6mL

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
67457-584-066745705840610 SYRINGE, GLASS in 1 CARTON (67457-584-06) / .6 mL in 1 SYRINGE, GLASS (67457-584-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4b65f642-87f7-4da5-a9c9-02cd1f8d9d16
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67457-584
  • NADAC price for package 67457058406

    GET /v1/drugs/nadac/67457058406

Use it

Look up 67457-584 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67457-584 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67457-584. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.